Reactive oxygen species as additional determinants for cytotoxicity of Clostridium difficile toxins A and B

Toxins

Volumn 8, Issue 1, 2016, Pages

  Frädrich, Claudia ^a   Beer, Lara Antonia ^b   Gerhard, Ralf ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Clostridium difficile infection; Cytotoxicity; NADPH oxidase; Neutrophils; Reactive oxygen species; Rho GTPases; Toxin

Indexed keywords

APOCYNIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; FORMYLPEPTIDE RECEPTOR; GLUTAMATE DEHYDROGENASE; HIGH MOBILITY GROUP B1 PROTEIN; LACTATE DEHYDROGENASE; PROTEIN CDC42; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; ENTEROTOXIN; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

CELL DAMAGE; CELL DEATH; CLOSTRIDIUM ACETOBUTYLICUM; CLOSTRIDIUM DIFFICILE INFECTION; CYTOTOXICITY; EC50; INFLAMMATION; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; ANIMAL; HUMAN; METABOLISM;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL DEATH; ENTEROTOXINS; HUMANS; REACTIVE OXYGEN SPECIES;

EID: 84955237555     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins8010025     Document Type: Review

References (80)

1. Rupnik, M.; Wilcox, M.H.; Gerding, D.N. Clostridium difficile infection: New developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7, 526–536.
2. Just, I.; Selzer, J.; Wilm, M.; von Eichel-Streiber, C.; Mann, M.; Aktories, K. Glucosylation of Rho proteins byClostridium difficile toxin B. Nature 1995, 375, 500–503.
3. Just, I.; Wilm, M.; Selzer, J.; Rex, G.; von Eichel-Streiber, C.; Mann, M.; Aktories, K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 1995, 270, 13932–13936.
4. Zeiser, J.; Gerhard, R.; Just, I.; Pich, A. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques. J. Proteome Res. 2013, 12, 1604–1618.
5. Voth, D.E.; Ballard, J.D. Clostridium difficile toxins: Mechanism of action and role in disease. Clin. Microbiol. Rev. 2005,18, 247–263.
6. Schwan, C.; Stecher, B.; Tzivelekidis, T.; van Ham, M.; Rohde, M.; Hardt, W.D.; Wehland, J.; Aktories, K. Clostridium difficile toxin cdt induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 2009, 5.
7. Gerding, D.N.; Johnson, S.; Rupnik, M.; Aktories, K. Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance. Gut Microbes 2014, 5, 15–27.
8. McDonald, L.C.; Killgore, G.E.; Thompson, A.; Owens, R.C., Jr.; Kazakova, S.V.; Sambol, S.P.; Johnson, S.; Gerding, D.N. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005, 353, 2433–2441.
9. Davies, S.P.; Reddy, H.; Caivano, M.; Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351, 95–105.
10. Tam, J.; Beilhartz, G.L.; Auger, A.; Gupta, P.; Therien, A.G.; Melnyk, R.A. Small molecule inhibitors of Clostridium difficile toxin b-induced cellular damage. Chem. Biol. 2015, 22, 175–185.
11. Olling, A.; Seehase, S.; Minton, N.P.; Tatge, H.; Schroter, S.; Kohlscheen, S.; Pich, A.; Just, I.; Gerhard, R. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb. Pathog. 2012, 52, 92–100.
12. Govind, R.; Dupuy, B. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog. 2012, 8.
13. Krivan, H.C.; Clark, G.F.; Smith, D.F.; Wilkins, T.D. Cell surface binding site for Clostridium difficile enterotoxin: Evidence for a glycoconjugate containing the sequence Gal alpha 1–3Gal beta 1–4GlcNAc. Infect. Immun. 1986, 53, 573–581.
14. Tucker, K.D.; Wilkins, T.D. Toxin a of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect. Immun. 1991, 59, 73–78.
15. Manse, J.S.; Baldwin, M.R. Binding and entry of Clostridium difficile toxin B is mediated by multiple domains. FEBS Lett. 2015, 24, 3945–3951.
16. Yuan, P.; Zhang, H.; Cai, C.; Zhu, S.; Zhou, Y.; Yang, X.; He, R.; Li, C.; Guo, S.; Li, S.; et al. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Res. 2015, 25, 157–168.
17. LaFrance, M.E.; Farrow, M.A.; Chandrasekaran, R.; Sheng, J.; Rubin, D.H.; Lacy, D.B. Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 2015, 112, 7073–7078.
18. Na, X.; Kim, H.; Moyer, M.P.; Pothoulakis, C.; LaMont, J.T. Gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. Infect. Immun. 2008, 76, 2862–2871.
19. Pothoulakis, C.; Gilbert, R.J.; Cladaras, C.; Castagliuolo, I.; Semenza, G.; Hitti, Y.; Montcrief, J.S.; Linevsky, J.; Kelly, C.P.; Nikulasson, S.; et al. Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficiletoxin A. J. Clin. Investig. 1996, 98, 641–649.
20. Pruitt, R.N.; Lacy, D.B. Toward a structural understanding of Clostridium difficile toxins A and B. Front. Cell. Infect. Microbiol. 2012, 2, 28.
21. Gerhard, R.; Frenzel, E.; Goy, S.; Olling, A. Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain. J. Med. Microbiol. 2013, 62, 1414–1422.
22. Papatheodorou, P.; Zamboglou, C.; Genisyuerek, S.; Guttenberg, G.; Aktories, K. Clostridial glucosylating toxins enter cells via clathrin-mediated endocytosis. PLoS ONE 2010, 5.
23. Jank, T.; Aktories, K. Structure and mode of action of clostridial glucosylating toxins: The ABCD model. Trends Microbiol. 2008, 16, 222–229.
24. Qa’Dan, M.; Spyres, L.M.; Ballard, J.D. pH-Induced conformational changes in Clostridium difficile toxin B. Infect. Immun. 2000, 68, 2470–2474.
25. Barth, H.; Pfeifer, G.; Hofmann, F.; Maier, E.; Benz, R.; Aktories, K. Low pH-induced formation of ion channels byClostridium difficile toxin B in target cells. J. Biol. Chem. 2001, 276, 10670–10676.
26. Giesemann, T.; Jank, T.; Gerhard, R.; Maier, E.; Just, I.; Benz, R.; Aktories, K. Cholesterol-dependent pore formation ofClostridium difficile toxin A. J. Biol. Chem. 2006, 281, 10808–10815.
27. Egerer, M.; Giesemann, T.; Jank, T.; Satchell, K.J.; Aktories, K. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J. Biol. Chem. 2007, 282, 25314–25321.
28. Meyer, G.K.; Neetz, A.; Brandes, G.; Tsikas, D.; Butterfield, J.H.; Just, I.; Gerhard, R. Clostridium difficile toxins A and B directly stimulate human mast cells. Infect. Immun. 2007, 75, 3868–3876.
29. Shen, A. Clostridium difficile toxins: Mediators of inflammation. J. Innate Immun. 2012, 4, 149–158.
30. Genth, H.; Dreger, S.C.; Huelsenbeck, J.; Just, I. Clostridium difficile toxins: More than mere inhibitors of Rho proteins. Int. J. Biochem. Cell Biol. 2008, 40, 592–597.
31. Donta, S.T.; Sullivan, N.; Wilkins, T.D. Differential effects of Clostridium difficile toxins on tissue-cultured cells. J. Clin. Microbiol. 1982, 15, 1157–1158.
32. Chaves-Olarte, E.; Weidmann, M.; Eichel-Streiber, C.; Thelestam, M. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J. Clin. Investig. 1997, 100, 1734–1741.
33. Nottrott, S.; Schoentaube, J.; Genth, H.; Just, I.; Gerhard, R. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases. Apoptosis 2007, 12, 1443–1453.
34. Qa’Dan, M.; Ramsey, M.; Daniel, J.; Spyres, L.M.; Safiejko-Mroczka, B.; Ortiz-Leduc, W.; Ballard, J.D. Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cell Microbiol. 2002, 4, 425–434.
35. Brito, G.A.; Fujji, J.; Carneiro-Filho, B.A.; Lima, A.A.; Obrig, T.; Guerrant, R.L. Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J. Infect. Dis. 2002, 186, 1438–1447.
36. Solomon, K.; Webb, J.; Ali, N.; Robins, R.A.; Mahida, Y.R. Monocytes are highly sensitive to Clostridium difficile toxin A-induced apoptotic and nonapoptotic cell death. Infect. Immun. 2005, 73, 1625–1634.
37. Lica, M.; Schulz, F.; Schelle, I.; May, M.; Just, I.; Genth, H. Difference in the biological effects of Clostridium difficiletoxin B in proliferating and non-proliferating cells. Naunyn Schmiedebergs Arch. Pharmacol. 2011, 383, 275–283.
38. Halliwell, B.; Cross, C.E. Oxygen-derived species: Their relation to human disease and environmental stress. Environ. Health Perspect. 1994, 102, 5–12.
39. Zhuang, S.; Simon, G. Peroxynitrite-induced apoptosis involves activation of multiple caspases in HL-60 cells. Am. J. Physiol. Cell Physiol. 2000, 279, C341–C351.
40. Bayir, H. Reactive oxygen species. Crit. Care Med. 2005, 33, S498–S501.
41. Waris, G.; Ahsan, H. Reactive oxygen species: Role in the development of cancer and various chronic conditions. J. Carcinog. 2006, 5, 14.
42. Afonso, V.; Champy, R.; Mitrovic, D.; Collin, P.; Lomri, A. Reactive oxygen species and superoxide dismutases: Role in joint diseases. Jt. Bone Spine 2007, 74, 324–329.
43. Thannickal, V.J.; Fanburg, B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000,279, L1005–L1028.
44. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48, 749–762.
45. Giembycz, M.A.; Lindsay, M.A. Pharmacology of the eosinophil. Pharmacol. Rev. 1999, 51, 213–340.
46. DeLeo, F.R.; Quinn, M.T. Assembly of the phagocyte NADPH oxidase: Molecular interaction of oxidase proteins. J. Leukoc. Biol. 1996, 60, 677–691.
47. Lacy, P.; Abdel-Latif, D.; Steward, M.; Musat-Marcu, S.; Man, S.F.; Moqbel, R. Divergence of mechanisms regulating respiratory burst in blood and sputum eosinophils and neutrophils from atopic subjects. J. Immunol. 2003, 170, 2670–2679.
48. Abdel-Latif, D.; Steward, M.; Macdonald, D.L.; Francis, G.A.; Dinauer, M.C.; Lacy, P. Rac2 is critical for neutrophil primary granule exocytosis. Blood 2004, 104, 832–839.
49. Hordijk, P.L. Regulation of nadph oxidases: The role of rac proteins. Circ. Res. 2006, 98, 453–462.
50. Sulciner, D.J.; Irani, K.; Yu, Z.X.; Ferrans, V.J.; Goldschmidt-Clermont, P.; Finkel, T. Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell. Biol. 1996, 16, 7115–7121.
51. Jiang, F.; Zhang, Y.; Dusting, G.J. NADPH oxidase-mediated redox signaling: Roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol. Rev. 2011, 63, 218–242.
52. Chumbler, N.M.; Farrow, M.A.; Lapierre, L.A.; Franklin, J.L.; Haslam, D.B.; Goldenring, J.R.; Lacy, D.B. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog. 2012,8.
53. Farrow, M.A.; Chumbler, N.M.; Lapierre, L.A.; Franklin, J.L.; Rutherford, S.A.; Goldenring, J.R.; Lacy, D.B. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell nadph oxidase complex. Proc. Natl. Acad. Sci. USA 2013, 110, 18674–18679.
54. Donald, R.G.; Flint, M.; Kalyan, N.; Johnson, E.; Witko, S.E.; Kotash, C.; Zhao, P.; Megati, S.; Yurgelonis, I.; Lee, P.K.;et al. A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile. Microbiology 2013, 159, 1254–1266.
55. Wohlan, K.; Goy, S.; Olling, A.; Srivaratharajan, S.; Tatge, H.; Genth, H.; Gerhard, R. Pyknotic cell death induced byClostridium difficile TcdB: Chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity. Cell Microbiol. 2014, 16, 1678–1692.
56. Son, Y.O.; Jang, Y.S.; Heo, J.S.; Chung, W.T.; Choi, K.C.; Lee, J.C. Apoptosis-inducing factor plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells. Apoptosis 2009, 14, 796–808.
57. Englert, R.P.; Shacter, E. Distinct modes of cell death induced by different reactive oxygen species: Amino acyl chloramines mediate hypochlorous acid-induced apoptosis. J. Biol. Chem. 2002, 277, 20518–20526.
58. Eguchi, Y.; Shimizu, S.; Tsujimoto, Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 1997, 57, 1835–1840.
59. Zhang, Z.; Park, M.; Tam, J.; Auger, A.; Beilhartz, G.L.; Lacy, D.B.; Melnyk, R.A. Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc. Natl. Acad. Sci. USA 2014, 111, 3721–3726.
60. He, D.; Hagen, S.J.; Pothoulakis, C.; Chen, M.; Medina, N.D.; Warny, M.; LaMont, J.T. Clostridium difficile toxin a causes early damage to mitochondria in cultured cells. Gastroenterology 2000, 119, 139–150.
61. Kim, H.; Rhee, S.H.; Kokkotou, E.; Na, X.; Savidge, T.; Moyer, M.P.; Pothoulakis, C.; LaMont, J.T. Clostridium difficiletoxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 mapk. J. Biol. Chem. 2005, 280, 21237–21245.
62. Qiu, B.; Pothoulakis, C.; Castagliuolo, I.; Nikulasson, S.; LaMont, J.T. Participation of reactive oxygen metabolites inClostridium difficile toxin A-induced enteritis in rats. Am. J. Physiol. 1999, 276, G485–G490.
63. Gerhard, R.; Burger, S.; Tatge, H.; Genth, H.; Just, I.; Hofmann, F. Comparison of wild type with recombinantClostridium difficile toxin a. Microb. Pathog. 2005, 38, 77–83.
64. Fang, F.C. Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies. Nat. Rev. Microbiol. 2004,2, 820–832.
65. Goy, S.D.; Olling, A.; Neumann, D.; Pich, A.; Gerhard, R. Human neutrophils are activated by a peptide fragment ofClostridium difficile toxin B presumably via formyl peptide receptor. Cell Microbiol. 2015, 17, 893–909.
66. Pothoulakis, C.; Sullivan, R.; Melnick, D.A.; Triadafilopoulos, G.; Gadenne, A.S.; Meshulam, T.; LaMont, J.T. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J. Clin. Investig. 1988, 81, 1741–1745.
67. Sun, C.; Wang, H.; Mao, S.; Liu, J.; Li, S.; Wang, J. Reactive oxygen species involved in CT26 immunogenic cell death induced by Clostridium difficile toxin B. Immunol. Lett. 2015, 164, 65–71.
68. Sun, C.; Wang, H.; Chen, S.; Li, Z.; Li, S.; Wang, J. Recombinant Clostridium difficile toxin B induces endoplasmic reticulum stress in mouse colonal carcinoma cells. Acta Biochim. Biophys. Sin. (Shanghai) 2014, 46, 973–981.
69. Beilhartz, G.L.; Tam, J.; Melnyk, R.A. Small molecules take a big step against Clostridium difficile. Trends Microbiol.2015, 23, 746–748.
70. Ryder, A.B.; Huang, Y.; Li, H.; Zheng, M.; Wang, X.; Stratton, C.W.; Xu, X.; Tang, Y.W. Assessment of Clostridium difficile infections by quantitative detection of TcdB toxin by use of a real-time cell analysis system. J. Clin. Microbiol.2010, 48, 4129–4134.
71. Song, L.; Zhao, M.; Duffy, D.C.; Hansen, J.; Shields, K.; Wungjiranirun, M.; Chen, X.; Xu, H.; Leffler, D.A.; Sambol, S.P.; et al. Development and validation of digital enzyme-linked immunosorbent assays for ultrasensitive detection and quantification of Clostridium difficile toxins in stool. J. Clin. Microbiol. 2015, 53, 3204–3212.
72. 2. Microbiology 2014, 160, 47–55.
73. Anderson, B.M.; Anderson, C.D.; van Tassell, R.L.; Lyerly, D.M.; Wilkins, T.D. Purification and characterization ofClostridium difficile glutamate dehydrogenase. Arch. Biochem. Biophys. 1993, 300, 483–488.
74. Sharp, S.E.; Ruden, L.O.; Pohl, J.C.; Hatcher, P.A.; Jayne, L.M.; Ivie, W.M. Evaluation of the C. Diff quik chek complete assay, a new glutamate dehydrogenase and a/b toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 2010, 48, 2082–2086.
75. Goldenberg, S.D.; Cliff, P.R.; French, G.L. Glutamate dehydrogenase for laboratory diagnosis of Clostridium difficileinfection. J. Clin. Microbiol. 2010, 48, 3050–3051.
76. Hillmann, F.; Fischer, R.J.; Saint-Prix, F.; Girbal, L.; Bahl, H. Perr acts as a switch for oxygen tolerance in the strict anaerobe clostridium acetobutylicum. Mol. Microbiol. 2008, 68, 848–860.
77. Jones, R.M.; Mercante, J.W.; Neish, A.S. Reactive oxygen production induced by the gut microbiota: Pharmacotherapeutic implications. Curr. Med. Chem. 2012, 19, 1519–1529.
78. Schroeder, B.O.; Wu, Z.; Nuding, S.; Groscurth, S.; Marcinowski, M.; Beisner, J.; Buchner, J.; Schaller, M.; Stange, E.F.; Wehkamp, J. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011, 469, 419–423.
79. Heap, J.T.; Pennington, O.J.; Cartman, S.T.; Carter, G.P.; Minton, N.P. The clostron: A universal gene knock-out system for the genus clostridium. J. Microbiol. Methods 2007, 70, 452–464.
80. Ng, Y.K.; Ehsaan, M.; Philip, S.; Collery, M.M.; Janoir, C.; Collignon, A.; Cartman, S.T.; Minton, N.P. Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: Allelic exchange using pyrEalleles. PLoS ONE 2013, 8.